Serum fluoride levels in ambulance staff after commencement of methoxyflurane administration compared to meta-analysis results for the general public. (2021)
Type of ContentJournal Article
PublisherNofer Institute of Occupational Medicine
OBJECTIVES: Ambulance officers administering methoxyflurane as an inhalational analgesic may be exposed to trace vapor. Fluoride is a methoxyflurane metabolite, and has been associated with acute renal failure in anesthesia patients and skeletal fluorosis with chronic elevated serum levels from other sources. However, there has been no direct measurement of serum fluoride in occupationally exposed ambulance officers. Thus, this study directly measures serum fluoride over a prolonged period in order to determine renal toxic and skeletal fluorosis risk to ambulance officers who are administering methoxyflurane. MATERIAL AND METHODS: Serum inorganic fluoride concentrations were measured in a prospective observational study of 12 emergency medical technicians (EMTs). The study took 7 serum fluoride measurements over 24 months. A meta-analysis of healthy adult serum fluoride ranges was also conducted. RESULTS: The typical healthy adult serum fluoride range was determined to be 0.21-2.11 μmol/l (p < 0.001). The EMTs' baseline median (IQR) serum fluoride concentrations were 0.4 μmol/l (0.2; 1.0) with maximum 1.6 μmol/l. The EMTs' overall median serum fluoride was 0.4 μmol/l (0.2; 1.3) with maximum 4.0 μmol/l, usually within healthy reference ranges. All results were ≤10% of the suggested single-dose renal toxic threshold. One result was above a threshold for skeletal fluorosis. The highest measured serum fluoride was 24% of the lowest level associated with radiologic evidence of fluorosis. There was no evidence overall of increasing serum fluoride levels. CONCLUSIONS: There was no evidence that EMTs' exposure to methoxyflurane resulted in sustained increased serum fluoride. These results imply EMTs' occupational safety from acute renal toxicity when activated carbon filtration is used on patient exhalation. However, 1 serum fluoride result above a skeletal fluorosis threshold suggests that the risk of mild skeletal fluorosis cannot be excluded.
CitationAllison SJ, Docherty PD, Pons D, Chase JG (2021). Serum fluoride levels in ambulance staff after commencement of methoxyflurane administration compared to meta-analysis results for the general public.. Int J Occup Med Environ Health.
This citation is automatically generated and may be unreliable. Use as a guide only.
Keywordsambulances; fluoride poisoning; fluorides; meta-analysis; methoxyflurane; prospective studies
ANZSRC Fields of Research32 - Biomedical and clinical sciences::3214 - Pharmacology and pharmaceutical sciences::321407 - Toxicology (incl. clinical toxicology)
32 - Biomedical and clinical sciences::3202 - Clinical sciences::320201 - Anaesthesiology
32 - Biomedical and clinical sciences::3202 - Clinical sciences::320207 - Emergency medicine
RightsAll rights reserved unless otherwise stated
Showing items related by title, author, creator and subject.
Allison SJ; Chase, Geoff; Pons, Dirk; Docherty, Paul (Elsevier BV, 2017)© 2017 Background - Methoxyflurane was used as an anaesthetic agent from 1958 until it was withdrawn around 1974 after dose-related patient nephrotoxicity was identified. It is now available only for administration via the ...
Water fluoridation and ethnic inequities in dental caries profiles of New Zealand children aged 5 and 12-13 years: analysis of national cross-sectional registry databases for the decade 2004-2013 Schluter, P.J.; Lee, M. (University of Canterbury. School of Health Sciences, 2016)Background: Gross and important inequities have historically existed in the oral health profiles of New Zealand children. Following the New Zealand Government's strategic oral health vision, launched in 2006, nationally ...
Effects of olanzapine on anxiety-related behaviour in male and female rats assessed after 21-24 and 42-45 days of chronic treatment. Lockington MR; Hughes RN (Ovid Technologies (Wolters Kluwer Health), 2020)Olanzapine can decrease anxiety and impair memory, but there is limited information about length of treatment or sex differences in its effectiveness. Therefore, effects of 21-24 and 41-45 days of treatment and sex differences ...